In accordance with information provided in connection with Surgical Science announcing the acquisition of Simbionix on July 28, 2021, a number of key individuals at Simbionix have acquired shares from Surgical Sciences' two largest owners. A total of 103,018 shares have been acquired by the key individuals from the two main owners and board members Jan Bengtsson (Marknadspotential AB – 58,360 shares) and Roland Bengtsson (Semelin Kapitalförvaltning AB – 44,658 shares), at a price of SEK 210.00 per share (corresponding to the subscription price in the directed new share issue carried out in connection with the acquisition).
Please refer to press releases dated July 28 2021 for further details.
Gothenburg, Sweden, August 31, 2021
Surgical Science Sweden AB (publ)
The press release is available in the attachment or via
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.